NCT06522581View on ClinicalTrials.gov

Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Hypoxic Ischemic Encephalopathy of Newborn
Interventions
DRUG

Citicoline Sodium

one group of neonates with confirmed HIE grade II and III will receive injection citicoline through IV route within 06 hours of birth

Trial Locations (1)

68000

RECRUITING

MH, Rawalpindi

All Listed Sponsors
lead

Armed Forces Hospital, Pakistan

OTHER